血管周围脂肪组织功能失调在冠状动脉微血管疾病中的作用研究进展
曹洁玮 , 刘彩霞 , 李勇 , 付晓倩 , 林静 , 刘彬 , 张炜 , 安占军
中国现代医学杂志 ›› 2026, Vol. 36 ›› Issue (17) : 36 -42.
血管周围脂肪组织功能失调在冠状动脉微血管疾病中的作用研究进展
Research progress on the role of perivascular adipose tissue dysfunction in coronary microvascular disease
冠状动脉微血管疾病(CMVD)是影响心肌灌注的重要病理状态,常表现为心绞痛及缺血相关症状,但冠状动脉造影通常未见显著管腔狭窄。近年来研究发现,血管周围脂肪组织(PVAT)不仅是血管的结构支撑组织,更是一种活跃的内分泌与旁分泌器官,能够通过调控免疫细胞极化、脂肪细胞表型、炎症反应及氧化应激等多种机制参与微血管功能调控。PVAT功能失调已被认为是CMVD发生、发展的关键因素。该文基于最新基础与临床研究,系统总结了CMVD的疾病机制、PVAT的解剖及功能特征、在CMVD中的作用机制,以及潜在干预策略,并提出未来研究方向,以期为CMVD的精准防治提供理论依据与实践指导。
Coronary microvascular disease (CMVD) represents a critical pathological condition that impairs myocardial perfusion, typically manifesting as angina and ischemia-related symptoms despite the absence of significant epicardial coronary stenosis on angiography. Recent studies have redefined perivascular adipose tissue (PVAT) not merely as a passive structural component of the vasculature but as a metabolically active endocrine and paracrine organ. PVAT exerts multifaceted regulatory effects on vascular homeostasis by modulating immune cell polarization, adipocyte phenotypic transformation, inflammatory signaling, and oxidative stress. Dysfunction of PVAT has emerged as a pivotal contributor to the onset and progression of CMVD. This review synthesizes recent advances from both experimental and clinical studies, focusing on the pathophysiological mechanisms of CMVD, the anatomical and functional characteristics of PVAT, its mechanistic role in microvascular regulation, and potential therapeutic strategies targeting PVAT. Furthermore, perspectives on future research directions are proposed to provide theoretical and practical insights for the precise prevention and management of CMVD.
| [1] |
Bradley C, Berry C. Definition and epidemiology of coronary microvascular disease[J]. J Nucl Cardiol, 2022, 29(4): 1763-1775. |
| [2] |
Antoniades C, Tousoulis D, Vavlukis M, et al. Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers[J]. Eur Heart J, 2023, 44(38): 3827-3844. |
| [3] |
张文娜, 朱浩, 王晓东. 血管周围脂肪与心血管疾病的研究进展[J]. 南京医科大学学报(自然科学版), 2023, 43(5): 725-731. |
| [4] |
熊小伟. SENP1促进血管周围脂肪组织米色化产生抗动脉粥样硬化作用及机制研究[D]. 南昌: 南昌大学, 2024. |
| [5] |
Hwej A, Al-Ferjani A, Alshuweishi Y, et al. Lack of AMP-activated protein kinase-α1 reduces nitric oxide synthesis in thoracic aorta perivascular adipose tissue[J]. Vascul Pharmacol, 2024, 157: 107437. |
| [6] |
刘笑迎, 邵静. 冠状动脉微血管功能障碍危险因素的研究进展[J]. 中国心血管病研究, 2023, 21(4): 289-293. |
| [7] |
Del Buono M G, Montone R A, Camilli M, et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review[J]. J Am Coll Cardiol, 2021, 78(13): 1352-1371. |
| [8] |
Toya T, Nagatomo Y, Ikegami Y, et al. Coronary microvascular dysfunction in heart failure patients[J]. Front Cardiovasc Med, 2023, 10: 1153994. |
| [9] |
Anderson R D, Petersen J W, Mehta P K, et al. Prevalence of coronary endothelial and microvascular dysfunction in women with symptoms of ischemia and no obstructive coronary artery disease is confirmed by a new cohort: the NHLBI-sponsored women's ischemia syndrome evaluation-coronary vascular dysfunction (WISE-CVD)[J]. J Interv Cardiol, 2019, 2019: 7169275. |
| [10] |
Murthy V L, Naya M, Taqueti V R, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes[J]. Circulation, 2014, 129(24): 2518-2527. |
| [11] |
Reventun P, Sánchez-Esteban S, Cook-Calvete A, et al. Endothelial ILK induces cardioprotection by preventing coronary microvascular dysfunction and endothelial-to-mesenchymal transition[J]. Basic Res Cardiol, 2023, 118(1): 28. |
| [12] |
黄克, 左可可, 顾宁. 基于血管内皮功能探讨冠状动脉微循环障碍"虚气留滞"病机的科学内涵[J]. 辽宁中医药大学学报, 2025, 27(7): 44-49. |
| [13] |
李梓涵, 袁蓉, 信琪琪, 冠状动脉微血管疾病的中西医发病机制和治疗进展[J]. 中国实验方剂学杂志, 2023, 29(9): 252-260. |
| [14] |
李志兵, 应如. 血管周围脂肪组织与心肺血管疾病的研究进展[J]. 中国心血管病研究, 2020, 18(9): 845-849. |
| [15] |
Zierold S, Buschmann K, Gachkar S, et al. Brain-derived neurotrophic factor expression and signaling in different perivascular adipose tissue depots of patients with coronary artery disease[J]. J Am Heart Assoc, 2021, 10(6): e018322. |
| [16] |
Nakladal D, Sijbesma J W A, Visser L M, et al. Perivascular adipose tissue-derived nitric oxide compensates endothelial dysfunction in aged pre-atherosclerotic apolipoprotein E-deficient rats[J]. Vascul Pharmacol, 2022, 142: 106945. |
| [17] |
赵涵, 强红丽, 陈倍望, 血管周围脂肪组织参与动脉粥样硬化发病机制的研究进展[J]. 临床与病理杂志, 2025, 45(1): 65-73. |
| [18] |
Tan N, Dey D, Marwick T H, et al. Pericoronary adipose tissue as a marker of cardiovascular risk: JACC review topic of the week[J]. J Am Coll Cardiol, 2023, 81(9): 913-923. |
| [19] |
Sowka A, Dobrzyn P. Role of perivascular adipose tissue-derived adiponectin in vascular homeostasis[J]. Cells, 2021, 10(6): 1485. |
| [20] |
Sigdel S, Udoh G, Albalawy R, et al. Perivascular adipose tissue and perivascular adipose tissue-derived extracellular vesicles: new insights in vascular disease[J]. Cells, 2024, 13(16): 1309. |
| [21] |
Stanek A, Brożyna-TkaczyK K, Myśliński W. The role of obesity-induced perivascular adipose tissue (PVAT) dysfunction in vascular homeostasis[J]. Nutrients, 2021, 13(11): 3843. |
| [22] |
Abd Rami A Z, Aminuddin A, Hamid A A, et al. Nicotine impairs the anti-contractile function of perivascular adipose tissue by inhibiting the PPARγ-adiponectin-AdipoR1 axis[J]. Int J Mol Sci, 2023, 24(20): 15100. |
| [23] |
Koenen M, Becher T, Pagano G, et al. Ablation of Prdm16 and beige fat identity causes vascular remodeling and elevated blood pressure[J]. Science, 2026, 391(6782): 306-313. |
| [24] |
Pan X X, Ruan C C, Liu X Y, et al. Perivascular adipose tissue-derived stromal cells contribute to vascular remodeling during aging[J]. Aging Cell, 2019, 18(4): e12969. |
| [25] |
Shi H, Kim H W, Weintraub N L. Macrophage immunometabolism in perivascular adipose tissue[J]. Arterioscler Thromb Vasc Biol, 2021, 41(2): 731-733. |
| [26] |
Farias-Itao D S, Pasqualucci C A, de Andrade R A, et al. Macrophage polarization in the perivascular fat was associated with coronary atherosclerosis[J]. J Am Heart Assoc, 2022, 11(6): e023274. |
| [27] |
Adachi Y, Ueda K, Nomura S, et al. Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling[J]. Nat Commun, 2022, 13(1): 5117. |
| [28] |
Liu X J, Jiang X, Hu J, et al. Exercise attenuates high-fat diet-induced PVAT dysfunction through improved inflammatory response and BMP4-regulated adipose tissue browning[J]. Front Nutr, 2024, 11: 1393343. |
| [29] |
Mu W J, Qian S W, Song Y J, et al. BMP4-mediated browning of perivascular adipose tissue governs an anti-inflammatory program and prevents atherosclerosis[J]. Redox Biol, 2021, 43: 101979. |
| [30] |
Chen J Y, Wu Y P, Li C Y, et al. PPARγ activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity[J]. J Biomed Sci, 2021, 28(1): 22. |
| [31] |
宋玮, 张钟艺, 王楷, 茱萸丸通过PPARγ/NF-κB信号通路促进巨噬细胞M2型极化防治动脉粥样硬化[J]. 中国中药杂志, 2024, 49(1): 243-250. |
| [32] |
Pulipaka S, Singuru G, Sahoo S, et al. Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation[J]. GeroScience, 2024, 46(2): 2391-2408. |
| [33] |
HAN F, LI K, PAN R Y, et al. Calycosin directly improves perivascular adipose tissue dysfunction by upregulating the adiponectin/AMPK/eNOS pathway in obese mice[J]. Food Funct, 2018, 9(4): 2409-2415. |
| [34] |
Han F, Hou N N, Liu Y P, et al. Liraglutide improves vascular dysfunction by regulating a cAMP-independent PKA-AMPK pathway in perivascular adipose tissue in obese mice[J]. Biomed Pharmacother, 2019, 120: 109537. |
| [35] |
陈健乔. 半夏白术天麻汤防治血管衰老及治疗老年高血压的疗效观察[D]. 山东中医药大学, 2024. |
| [36] |
靳敖. 半夏白术天麻汤调节脂解平衡的作用研究[D]. 山东中医药大学, 2024. |
| [37] |
Wang A, Dong S J, Liu B H, et al. The role of RUNX1/NF-κB in regulating PVAT inflammation in aortic dissection[J]. Sci Rep, 2024, 14(1): 9960. |
| [38] |
Boucher J M, Robich M, Scott S S, et al. Rab27a regulates human perivascular adipose progenitor cell differentiation[J]. Cardiovasc Drugs Ther, 2018, 32(5): 519-530. |
| [39] |
高桂英, 胡阳, 张世益, 运动康复改善冠状动脉微循环障碍的相关机制研究进展[J]. 中国全科医学, 2025, 28(20): 2570-2576. |
河北省自然科学基金资助项目(H2025206786)
/
| 〈 |
|
〉 |